scispace - formally typeset
H

Huahao Shen

Researcher at Zhejiang University

Publications -  221
Citations -  7335

Huahao Shen is an academic researcher from Zhejiang University. The author has contributed to research in topics: Inflammation & Asthma. The author has an hindex of 38, co-authored 199 publications receiving 5283 citations. Previous affiliations of Huahao Shen include Guangzhou Medical University.

Papers
More filters
Journal ArticleDOI

Clinical and Inflammatory Characteristics of the Chinese APAC Cough Variant Asthma Cohort

TL;DR: Cough variant asthma is distinctive from classic asthma in regard to clinical features, lung function, and airway inflammation and quality of life is badly impaired as well in spite of better asthma control scores.
Journal ArticleDOI

Human C-C chemokine receptor 3 monoclonal antibody inhibits pulmonary inflammation in allergic mice

TL;DR: The inhibition of airway inflammation and mucus overproduction by the antibody suggested that the blockade of CCR3 is an appealing therapeutical target for asthma.
Journal ArticleDOI

Activating Transcription Factor 3 Is Essential for Cigarette Smoke-Induced Mucin Expression via Interaction with Activator Protein-1.

TL;DR: It is demonstrated that ATF3 may be involved in activator protein-1 signaling and transcriptional promotion of CS-induced MUC5AC expression in airway epithelial cells.
Journal ArticleDOI

Characteristics of different asthma phenotypes associated with cough: a prospective, multicenter survey in China

TL;DR: Wang et al. as mentioned in this paper compared the clinical and pathophysiological characteristics of CPA, CVA, and classic asthma patients to determine any differential phenotypic traits, and found that CPA patients more frequently presented with cough as the initial symptom, and laryngeal symptoms (p < 0.001), had less symptoms related with rhinitis/sinusitis and gastroesophageal reflux, while the proportion of COPD and bronchiectasis was higher in CA patients.
Journal ArticleDOI

Nuclear erythroid 2 p45-related factor-2 Nrf2 ameliorates cigarette smoking-induced mucus overproduction in airway epithelium and mouse lungs.

TL;DR: Nrf2 negatively regulated smoking-induced mucus production in vitro and in vivo, suggesting therapeutic potentials of this factor in airway diseases with hypersecreted mucus.